GNRH1 and Stroke: Another database study, within the United Kingdom’s General Practice Research Database population, analyzed 22,310 patients with prostate cancer and provided evidence that different types of ADT, including GnRH agonists, oral antiandrogens, combined androgen blockade, bilateral orchiectomy, and others, may increase the risk of stroke and transient ischemic attacks [19].